Proteomics International Laboratories Limited
ASX:PIQ.AX
Overview | Financials
Company Name | Proteomics International Laboratories Limited |
Symbol | PIQ.AX |
Currency | AUD |
Price | 0.6 |
Market Cap | 78,601,799 |
Dividend Yield | 0% |
52-week-range | 0.55 - 1.4 |
Industry | Biotechnology |
Sector | Healthcare |
CEO | Dr. Richard John Lipscombe M.A., MA (Oxford), Ph.D., Ph.D., (London) |
Website | https://www.proteomics.com.au |
An error occurred while fetching data.
About Proteomics International Laboratories Limited
Proteomics International Laboratories Limited operates as a medical technology company with a focus on the area of proteomics. It provides PromarkerD, a predictive test for diabetic kidney disease; and develops diagnostic tests for endometriosis and giardia. The company also offers analytical services, including specialist contract research. Proteomics International Laboratories Ltd
Related Stocks
Financials
Numbers are in millions USD
Numbers are in millions USD